FPN || Oncology

VIDEO: What was the most interesting thing you learned at the meeting?

Posted on: 14/12/2014 - 14:27

SAN ANTONIO – Our reporter Michele Sullivan asked selected attendees at the San Antonio Breast Cancer Symposium to identify the most interesting or practice-changing study presented at the meeting....

Field of Interest: Pulmonology

Type: News Item

VIDEO: What was the most interesting thing you learned at the meeting?

Posted on: 14/12/2014 - 14:27

Field of Interest: Oncology

Type: News Item

SOFT trial endorses selective ovarian suppression in early breast cancer

Posted on: 12/12/2014 - 16:57

SAN ANTONIO – Adding ovarian suppression to 5 years of tamoxifen in women with hormone receptor–positive early breast cancer who remain premenopausal following chemotherapy provides a markedly...

Field of Interest: Oncology

Type: News Item

Adjuvant capecitabine adds no advantage to bisphosphonate in elderly breast cancer patients

Posted on: 12/12/2014 - 14:03

SAN ANTONIO – The combination of capecitabine plus the bisphosphonate ibandronate didn’t improve disease-free survival in elderly women with moderate- or high-risk breast cancers. After 5 years,...

Field of Interest: Oncology

Type: News Item

North America has highest rate of obesity-related cancers

Posted on: 11/12/2014 - 21:08

For those cancers in which risk is associated with high body mass index, North America has the highest percentage of cancer incidence attributable to obesity, according to a population-based study in...

Field of Interest: Oncology

Type: News Item

Pembrolizumab shows efficacy in advanced triple-negative breast cancer patients

Posted on: 11/12/2014 - 14:59

SAN ANTONIO – Roughly one in five women with heavily pretreated, advanced triple-negative breast cancer experienced a durable response to monotherapy using the novel immune checkpoint inhibitor...

Field of Interest: Oncology

Type: News Item

Pembrolizumab shows efficacy in advanced triple-negative breast cancer patients

Posted on: 11/12/2014 - 14:59

SAN ANTONIO – Roughly one in five women with heavily pretreated, advanced triple-negative breast cancer experienced a durable response to monotherapy using the novel immune checkpoint inhibitor...

Field of Interest: Pulmonology

Type: News Item

Ultrasound screening for dense breasts is high cost, offers little benefit

Posted on: 08/12/2014 - 22:00

Supplemental screening ultrasonography would add substantial costs while providing little clinical benefit after a negative screening mammography in women with dense breasts, according to three...

Field of Interest: Oncology

Type: News Item

Ultrasound screening for dense breasts is high cost, offers little benefit

Posted on: 08/12/2014 - 22:00

Supplemental screening ultrasonography would add substantial costs while providing little clinical benefit after a negative screening mammography in women with dense breasts, according to three...

Field of Interest: Pulmonology

Type: News Item

No increase in prostate cancer with testosterone therapy

Posted on: 05/12/2014 - 13:36

A study of hypogonadal men undergoing testosterone therapy has found a lower rate of prostate cancer than previously recorded in screening studies, suggesting the therapy does not increase prostate...

Field of Interest: Oncology

Type: News Item

« first
‹ previous
…
9
10
11
12
13
14
15
16
17
…
next ›
last »

Newsletters

Stay informed on our latest news!

Latest Newsletters

randomness

You are here

Newsletters

Latest Newsletters